CStone Pharmaceuticals (HKSE:02616) Other Long Term Assets : HK$0.0 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Other Long Term Assets?

CStone Pharmaceuticals's other long-term assets for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

CStone Pharmaceuticals's quarterly other long-term assets increased from Jun. 2022 (HK$16.1 Mil) to Dec. 2022 (HK$28.2 Mil) but then stayed the same from Dec. 2022 (HK$28.2 Mil) to Jun. 2023 (HK$0.0 Mil).

CStone Pharmaceuticals's annual other long-term assets declined from Dec. 2021 (HK$67.8 Mil) to Dec. 2022 (HK$28.2 Mil) and declined from Dec. 2022 (HK$28.2 Mil) to Dec. 2023 (HK$6.3 Mil).

CStone Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for CStone Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Other Long Term Assets Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

44.81

97.19

67.77

28.19

6.34

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial									67.77	16.14	28.19	-	6.34

CStone Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines